CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Grant or award Director acquired 24,000 shares (grant or award)
- 4 Grant or award Director acquired 19,125 shares (grant or award)
- 4 Grant or award Director acquired 31,406 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 19,312 shares (grant or award)
- 4 Grant or award President and CEO acquired 37,080 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 19,312 shares (grant or award)
- 4 Grant or award Vice President of Operations acquired 15,128 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 17,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 400 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,205 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Operations gave up 2,023 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 4,958 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,582 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 1,200 shares at $2.90 ($3,480)
- 4 Open-market buy President and CEO bought 400 shares at $2.95 ($1,180)
- 4 Open-market buy President and CEO bought 3,500 shares at an average $2.59 ($9,081)
- 4 Open-market buy President and CEO bought 3,400 shares at $3.15 ($10,710)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 567 shares (option exercise)
Page 12 of 23 · 442 filings